Best Niche Antibody-based Biologics

CHIEF EXECUTIVE OFFICER

Yen-Ming Hsu

An accomplished biotech scientist specialized in therapeutic target identification protein engineering for immune-oncological indications. Yen-Ming worked in Biogen for over 20 years heading the Drug Development Department. He was a post-doctoral fellow with Professor Guidotti’s Harvard University. Yen-Ming obtained his Ph.D. in Biochemistry from Michigan State University and a Bachelor degree in Pharmacy from Taipei Medical College. Yen-Ming published 40 + peer-reviewed articles and invited reviews, has engineered over 170 proteins and has 64 granted patents.